A Clinico-biological Database of Lung Cancers
NCT03387865 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2026-05-22
Summary
This prospective, single-center, interventional study is conducted in order to achieve a biological bank accompanied by clinical data. Blood samples, optional tumor tissue and fecal samples are collected, processed and banked for all the included subjects. Those samples are collected before the start of treatment, at the time of first tumor assessment, at the time of first and second disease progression. The subjects are treated according to standard of care.
Clinical data are collected at each sampling time. The primary objective of the study is to identify biological, clinical and tumoral factors associated with tumor response according SOC treatment.
Conditions
Interventions
- PROCEDURE
-
tissue biopsies
additional biopsies will be performed during a diagnostic or therapeutic procedure, in order to sample tumor tissue and healthy tissue.
- PROCEDURE
-
blood sampling
additional blood samples will be collected during a SOC sampling procedure (2 EDTA 7.5 ml tubes, 2 SST 7.5 ml tubes and 2 citrate 5 ml tubes)
- GENETIC
-
DNA banking
constitutional and somatic genetic alterations will be analysed for subjects who consent, from either tumor or healthy tissue, or whole blood buffy coat after centrifugation
Sponsors & Collaborators
-
Institut Pasteur de Lille
collaborator OTHER -
University of Lille Nord de France
collaborator OTHER -
University Hospital, Lille
lead OTHER
Principal Investigators
-
Alexis CORTOT, MD,PhD · University Hospital, Lille
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-13
- Primary Completion
- 2032-03-31
- Completion
- 2032-03-31
Countries
- France
Study Locations
More Related Trials
-
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
NCT02597738 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Specimen Banking From Patients With Lung Cancer
NCT01585675 ·Status: RECRUITING
-
Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
NCT00693836 ·Status: UNKNOWN
-
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
NCT05415358 ·Status: ACTIVE_NOT_RECRUITING
-
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study
NCT06105177 ·Status: RECRUITING
-
Cancer Panel From Blood of Lung Cancer Patients
NCT03235765 ·Status: UNKNOWN
-
A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer
NCT03258788 ·Status: COMPLETED
-
Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA
NCT03926260 ·Status: COMPLETED ·Phase: NA
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)
NCT02448758 ·Status: COMPLETED
-
Metabolic and Microbial Profiling of Lung Cancer
NCT03998189 ·Status: TERMINATED ·Phase: NA
-
Metabolomics Predict Therapy Response
NCT03736993 ·Status: COMPLETED ·Phase: NA
-
Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Cancer
NCT06244355 ·Status: RECRUITING
-
LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
NCT02511288 ·Status: RECRUITING
-
Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers
NCT01647867 ·Status: COMPLETED ·Phase: NA
-
Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer
NCT07042867 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research
NCT05669105 ·Status: RECRUITING
-
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
NCT04720339 ·Status: RECRUITING ·Phase: NA
-
Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients
NCT06481813 ·Status: RECRUITING ·Phase: NA
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)
NCT05267041 ·Status: RECRUITING ·Phase: NA
-
Circulating Tumor DNA in Patients at High Risk for Lung Cancer
NCT02715102 ·Status: TERMINATED
-
PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer
NCT02827344 ·Status: COMPLETED
-
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer
NCT03492801 ·Status: TERMINATED